Saudi Arabia · Delayed Price · Currency is SAR National Medical Care Company Earnings Call Transcripts
Fiscal Year 2026
-
Revenue and patient volumes rebounded strongly in Q2 2026, led by GOSI and insurance segments, driving record net profit and margin recovery. Capacity utilization and operational efficiency improved, while management expects positive momentum to continue into H2.
-
Q1 2026 saw stable revenue and strong patient growth, but profitability declined due to seasonal case mix and higher costs. Management expects recovery in margins and volumes as seasonal effects subside, with ongoing expansion and price negotiations set to support future growth.
Fiscal Year 2025
-
Revenue grew 24% year-on-year to SAR 1.6 billion, with patient volumes up 33% and gross profit up 31%. Margin improvement and expansion are targeted through operational efficiencies and contract renegotiations, while receivables and insurance claim rejections remain key risks.
-
Strong nine-month results featured 41% patient growth, 32% revenue increase, and 17% higher net profit, driven by expanded capacity, Al Salam integration, and diversified services. Cash flow and liquidity remain robust, with ongoing strategic investments and contract renegotiations.
-
Revenue grew 32% and net profit rose 10% year-on-year in H1 2025, driven by strong patient volume growth and successful integration of Al Salam Hospital. Cash reserves increased to SAR 477 million, and strategic expansion—including Al Narjis Hospital—remains on track.